CIFN

(redirected from Consensus Interferon)
AcronymDefinition
CIFNConsensus Interferon (molecular biology)
CIFNComplexo Industrial Ford Nordeste (Portuguese: Ford Industrial Complex Northeast; Ford Motor Co.; Brazil)
CIFNCentral Interior First Nations (Canada)
CIFNCentral Illinois Fire Network (Altamont, IL)
CIFNChemotherapy-Induced Fever and Neutropenia (pharmacotherapy)
References in periodicals archive ?
Consensus interferon (CIFN) is a recombinant type 1 IFN containing 166 amino acids.
He said after new research findings there is a new ray of hope with newly launched Consensus Interferon (Infergen).
Interferon alfacon-1, also known as consensus interferon, is bioengineered to have a different amino acid sequence than interferon alfa2a and -2b.
Newer therapies of HCV have also been discussed namely oral interferon inducers, immunomodulating drugs, newer interferons such as consensus interferon and albuferon.
LOS ANGELES -- Extended combination therapy with consensus interferon for 72 weeks appears to help improve the viral response of patients with chronic hepatitis C virus who have previously relapsed after a 48-week course of treatment, according to a study presented at the annual Digestive Disease Week.
Los Angeles -- Extended combination therapy with consensus interferon for 72 weeks appears to help improve the viral response of patients with chronic hepatitis C who have previously relapsed after a 48-week course of treatment, according to a study presented at the annual Digestive Disease Week.
of Tokyo to market Consensus Interferon, which fights the hepatitis C virus.
At the meeting, early studies were presented on two new types of interferon, pegylated consensus interferon, which is a bioengineered interferon that can be given at a high dose, and an albumin-interferon fusion protein, which has a long half-life and would be given only once every 2-4 weeks.
Rajender Reddy and other members of the Consensus Interferon Study Group.
Trials underway are using high-dose interferon or consensus interferon, a synthetic recombinant drug, in daily dosing for several weeks followed by maintenance doses for a total treatment time of 1 year.